EMERYVILLE, Calif. (AP) _ Zogenix Inc. (ZGNX) on Thursday reported a loss of $290.5 million in its third quarter.
On a per-share basis, the Emeryville, California-based company said it had a loss of $6.75. Losses, adjusted for non-recurring costs, were 95 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.05 per share.
The drugmaker posted revenue of $630,000 in the period.
Zogenix shares have climbed 21% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $44.08, rising slightly in the last 12 months.